Ouachita County Medical Center Opts for SafeTrace Tx(R) Transfusion Management System From Global Med Technologies(R), Inc. DENVER, May 5 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for its SafeTrace Tx(R)* advanced transfusion management system with Oauchita County Medical Center. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) "We chose SafeTrace Tx for its comprehensive safety features and precise tracking of patients and blood products," said Cheryl Clay, a Medical Technologist at Ouachita County Medical Center. Ms. Clay also stated, "SafeTrace Tx will enable us to provide high quality services and blood products to our patients with greater efficiency." Thomas Marcinek, President and Chief Operating Officer of Global Med Technologies, Inc., said, "We are pleased to have been selected to provide our products and services to enhance the transfusion service management of an established organization such as Ouachita County Medical Center." Mr. Marcinek added, "The delivery of accessible, quality healthcare is important to both Ouachita County Medical Center and Global Med Technologies, Inc." About Ouachita County Medical Center Ouachita County Medical Center, an acute care hospital located in Camden, Arkansas, is part of the Rural Hospital Educational and Telemedicine Program and is fully licensed by the State of Arkansas. For more information about Ouachita County Medical Center, please visit its web site at http://www.ouachitamedcenter.com/. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. blood centers and transfusion services. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Press, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, , or Investors, Tom Marcinek, President and COO, +1-916-404-8413, , both of Wyndgate Technologies Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ http://www.globalmedtech.com/

Copyright